Multiomics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Component (Instruments, Consumables, Software and Services), By Type (Single - cell, and Bulk), By Platform (Genomic, Transcriptomics, Proteomics, Metabolomics, and Integrated Omics), By Application (Cell biology, Oncology, Neurology, Immunology, and Others), By End User (Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, Clinical Research Organizations, and Others), By Region Forecast 2019-2030

Multiomics Market size was valued at US$ 2,871.3 million in 2023 and is projected to grow at 12.9% CAGR  from 2024 – 2030. To study biological systems, the market is a field that integrates several omics specialties, including proteomics, metabolomics, and genomics. The word omics refers to the sum of constituents within a cell. The key driving factors fueling the market are the rising prevalence of chronic illnesses like cancer, diabetes, and heart diseases, increasing usage of multiomics in personalized medicine, growing investments and funding in multiomics research, and technological advancement in omics technologies.

However, the high cost and high maintenance of infrastructure which results in less affordability, complexity in the adoption of technology, and high cost of storing the data are hampering the growth of the market. The emerging opportunities of the market are the development of biomarkers for disease diagnosis, the emergence of cloud computing and artificial intelligence in multiomics data analysis, swift technological advancements, development of more user-friendly platforms which will additionally improve the standards. Global market trends are advancements in omics technologies that have further propelled the growth of the market, the application is providing more accessibility in the field of research and diagnostics and also in therapeutic development.

Moreover, the surge in demand for the launch of new multi-omics platforms with more enhanced capabilities and more accurate diagnosis also surges the growth of the market. For example, In June 2021, SCIEX released the molecule profiler app and the OneOmics package of tools which is a cloud-based platform used for metabolite, protein, and lipid analysis on large-size data sets. Additionally, it makes it simpler to process research and analyze massive amounts of data from multi-omics investigations.

Multiomics Market Key Developments

•  In November 2019, QIAGEN launched QIAseq multimodal product which was developed for main focus on DNA and RNA enrichment and analyses.
•  In November 2023, Illumia introduced an advanced liquid biopsy assay, TSO Oncology 500 ctDNA v2 specially designed to facilitate comprehensive genomic profiling of solid tumors.
•  In January 2024, Akoya Biosciences and Thermo Fisher Scientific company announced a release of license & distribution agreement to deliver spatial multi-omics solutions.